Ian Degeling’s Post

View profile for Ian Degeling, graphic

Co-Founder & CTO bij SeraNovo B.V.

Many new drugs struggle with poor absorption and bioavailability if they exceed Lipinski's Rule of 5. At SeraNovo, we create advanced formulations to overcome these challenges. Discover our innovative technology to enhance your compound's bioavailability. https://lnkd.in/dMjN4v9C #SeraNovo #SolvingtheInsoluble #Lipinskisruleof5

View organization page for SeraNovo, graphic

2,912 followers

If a compound exceeds Lipinski's Rule of 5, it may suffer from poor absorption and bioavailability when taken orally, limiting its potential for patients. Many new chemical entities face this challenge and need specialized formulation strategies to achieve sufficient bioavailability. At SeraNovo, we specialize in formulating these complex compounds to ensure enhanced bioavailability and optimal absorption. Discover how our proprietary formulation technology can support you. Get in touch with us today! #SeraNovo #SolvingtheInsoluble #Lipinskisruleof5

To view or add a comment, sign in

Explore topics